1. 367 A phase 1/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with atezolizumab in patients with advanced solid tumors. (9th November 2020) Authors: Luke, Jason; Janku, Filip; Olszanski, Anthony; Leach, Kevin; Iyer, Radhakrishnan; Abbas, Atif Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗